Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, a decline of 41.8% from the February 13th total of 6,700 shares. Based on an average daily volume of 14,700 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are sold short.
Invesco Nasdaq Biotechnology ETF Stock Performance
IBBQ opened at $22.21 on Monday. The business has a 50 day moving average price of $22.29 and a 200 day moving average price of $22.92. Invesco Nasdaq Biotechnology ETF has a twelve month low of $20.14 and a twelve month high of $24.84. The firm has a market cap of $39.31 million, a P/E ratio of 17.68 and a beta of 0.61.
Invesco Nasdaq Biotechnology ETF Announces Dividend
The business also recently announced a dividend, which was paid on Friday, December 27th. Investors of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.
Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Top Biotech Stocks: Exploring Innovation Opportunities
- How to Build the Ultimate Everything ETF Portfolio
- Comparing and Trading High PE Ratio Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.